Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
BMC Endocrine Disorders|September 6, 2012
Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional studyMiguel Angel Gómez-Sámano, Daniel Cuevas-Ramos, Roopa Mehta, et al.
Lancet (London, England)|June 9, 2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trialPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
European Heart Journal|February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialMichel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.
Diabetes Research and Clinical Practice|April 1, 2015
Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continentsPhilip D Home, Marie-Paule Dain, Nick Freemantle, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 11, 2011
Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): MexicoDaniel Cuevas Ramos, Roopa Mehta, Julieta De La Luz Castro, et al.
Diabetes, Obesity & Metabolism|July 4, 2020
Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelinesRoopa Mehta, Roger Chen, Takahisa Hirose, et al.
Lipids in Health and Disease|May 6, 2021
Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equationsArsenio Vargas-Vázquez, Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, et al.
Cardiovascular Diabetology|January 11, 2011
Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based surveyNancy Reynoso-Noverón, Roopa Mehta, Paloma Almeda-Valdes, et al.
JCEM Case Reports|March 31, 2025
Remission of Statin-associated Autoimmune Necrotizing Myopathy With Sequential Immunotherapy: A Well-studied PatientFrancisco J Gómez-Pérez, Erwin Chiquete-Anaya, Andrea G Moncayo-Sánchez, et al.
Diabetology & Metabolic Syndrome|July 22, 2025
Consensus statement on standardizing CGM evaluation metrics in Latin America: an expert approachMauro Scharf, Karen Feriz, Carlos Yepes, et al.
Pageof 15